Fred Turner is CEO of Curative, a company that’s just announced a head-scratching pivot: from COVID-testing company to large-group commercial health plan.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh